Dextromethorphan (DM) Dosage Recommendations for Pediatric Patients
For pediatric patients, dextromethorphan cough syrup should be dosed according to age, with children under 4 years of age not receiving any dextromethorphan. 1
Age-Based Dosing Guidelines
The FDA-approved dosing for dextromethorphan cough syrup is as follows:
- Children under 4 years: Do not use
- Children 4 to under 6 years: 2.5 mL every 12 hours, not to exceed 5 mL in 24 hours
- Children 6 to under 12 years: 5 mL every 12 hours, not to exceed 10 mL in 24 hours
- Children 12 years and older and adults: 10 mL every 12 hours, not to exceed 20 mL in 24 hours 1
Administration Considerations
- Always use the dosing cup provided with the medication
- Shake the bottle well before measuring
- Do not use the dosing cup with other products
- Follow the recommended dosing schedule or as directed by a physician 1
Efficacy and Safety Considerations
Efficacy
- Research shows dextromethorphan provides modest benefits for cough suppression in children 6-11 years, with a 21.0% reduction in total coughs over 24 hours and 25.5% reduction during daytime compared to placebo 2
- The American Academy of Pediatrics and CHEST guidelines do not strongly support the use of OTC cough medications including dextromethorphan for children due to limited efficacy evidence 3
Safety Concerns
Most adverse events associated with dextromethorphan in children occur with overdoses rather than therapeutic doses 4
Common adverse effects include:
- Central nervous system effects (e.g., ataxia)
- Autonomic symptoms (e.g., tachycardia)
- Flushing and/or urticarial rash (18.1% of patients)
- Dystonia (5.4% of patients) 4
Serious toxicity is rare with therapeutic doses but has been reported with overdoses 5
Children under 4 years are at higher risk for adverse effects, with 60% of adverse events occurring in this age group 4
Weight-Based Dosing Considerations
While the FDA-approved dosing is age-based, some research suggests weight-based dosing may be more appropriate:
- Studies suggest a dose of approximately 0.5 mg/kg may balance efficacy with safety 6
- Doses ranging from 0.45 to <0.60 mg/kg may provide better symptomatic relief than lower doses (0.35 to <0.45 mg/kg) 6
- Higher doses (0.60-0.94 mg/kg) may increase the risk of adverse events 6
Important Warnings and Precautions
- The FDA has issued warnings against using OTC cough medications in young children due to safety concerns 3
- In 2018, the FDA altered labeling for prescription opioid cough medicines to limit their use to adults ≥18 years 3
- Manufacturers have voluntarily relabeled OTC cough products with "do not use in children under 4 years of age" 3
- Unsupervised ingestion is a significant risk factor for adverse events, accounting for 69% of cases with adverse events 4
Alternative Approaches
- CHEST guidelines suggest that honey may offer more relief for cough symptoms than no treatment or diphenhydramine, and is comparable to dextromethorphan 3
- Treatment of the underlying cause of cough is preferred over symptomatic treatment with cough suppressants 3
Remember to store all medications out of reach of children to prevent accidental ingestions, which account for the majority of adverse events related to dextromethorphan in pediatric patients.